DUREZOL is a Ophthalmic Emulsion in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Difluprednate.
Product ID | 0078-0862_830dd64e-8b1a-4bc4-86bd-e0a0915b59e7 |
NDC | 0078-0862 |
Product Type | Human Prescription Drug |
Proprietary Name | DUREZOL |
Generic Name | Difluprednate |
Dosage Form | Emulsion |
Route of Administration | OPHTHALMIC |
Marketing Start Date | 2011-01-25 |
Marketing Category | NDA / |
Application Number | NDA022212 |
Labeler Name | Novartis Pharmaceuticals Corporation |
Substance Name | DIFLUPREDNATE |
Active Ingredient Strength | 1 mg/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-07-05 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0065-9240 | DUREZOL | DUREZOL |
0078-0862 | DUREZOL | difluprednate |
0781-6000 | DUREZOL | Difluprednate Ophthalmic Emulsion |
69097-341 | DIFLUPREDNATE | DIFLUPREDNATE |
76282-708 | DIFLUPREDNATE | DIFLUPREDNATE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
DUREZOL 77830018 3784208 Live/Registered |
NOVARTIS AG 2009-09-18 |
DUREZOL 77340065 not registered Dead/Abandoned |
Sirion Therapeutics, Inc. 2007-11-29 |